Sponsor Pipeline

Imbria Pharmaceuticals, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07023614 A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic… Non-obstructive Hypertrophic Cardiomyopathy Recruiting
Get alerts when Imbria Pharmaceuticals, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free